Role of Hysterectomy in the Treatment of Borderline Ovarian Tumors

CompletedOBSERVATIONAL
Enrollment

168

Participants

Timeline

Start Date

January 10, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

January 31, 2025

Conditions
Hysterectomy
Trial Locations (3)

33100

Ospedale universitario, Azienda Sanitaria Universitaria Friuli Centrale, Udine

40138

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

00136

Fondazione Policlinico Universitario A. Gemelli, IRCCS, Roma

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT06825468 - Role of Hysterectomy in the Treatment of Borderline Ovarian Tumors | Biotech Hunter | Biotech Hunter